Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 171 | 137 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 44 | 50 |
|
Invitae Primary Ciliary Dyskinesia Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 49 | 37 |
|
Primary Ciliary Dyskinesia (PCD) via the DNAI2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel PreventionGenetics, part of Exact Sciences United States | 44 | 51 |
|
Primary Immunodeficiency Panel Baylor Genetics United States | 1 | 463 |
|
GeneAware™ Expanded Panel (Female) Baylor Genetics United States | 1 | 422 |
|
GeneAware™ Expanded Panel (Male) Baylor Genetics United States | 1 | 382 |
|
GeneAware™ Expanded Plus Panel (Female) Baylor Genetics United States | 1 | 446 |
|
GeneAware™ Expanded Plus Panel (Male) Baylor Genetics United States | 1 | 401 |
|
Primary ciliary dyskinesia (WES-based NGS panel of 34 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 34 |
|
Congenital Heart Defects Panel CGC Genetics Unilabs Portugal | 1 | 208 |
|
CGC Genetics Unilabs Portugal | 1 | 107 |
|
CGC Genetics Unilabs Portugal | 1 | 184 |
|
Ciliary dyskinesia, primary 9 (sequence analysis of DNAI2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Immunodeficiencies and Immunologic Diseases Panel (Complete) Mendelics Brazil | 1 | 397 |
|
Primary Ciliary Dyskinesia Panel Mendelics Brazil | 1 | 35 |
|
GLOBAL CILIOPATHIES EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 273 |
|
SUDDEN DEATH/ IDIOPATHIC VENTRICULAR FIBRILLATION EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 394 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.